The biotechnology company Moderna assured this morning that its vaccine against Covid-19 is effective against the variants of the virus identified in the United Kingdom and South Africa.
The study was conducted in collaboration with the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).
According to the company, the vaccine should protect “against the variants detected to date.”
Similarly, it was established that they will emphasize their “clinical strategy to proactively address the pandemic as the virus continues to evolve.”
“As we seek to defeat the Covid-19 virus, which has created a global pandemic, we believe it is imperative to be proactive as the virus evolves. We are encouraged by this new data, which reinforces our confidence that Moderna’s vaccine against Covid-19 should protect against these newly detected variants, ”said Stéphane Bancel, CEO of Moderna.
Likewise, expreso anticipated that “out of great caution and taking advantage of the flexibility of our mRNA platform, we are advancing an emerging reinforcement candidate variant against the variant identified for the first time in the Republic of South Africa to determine if it will be more effective to increase titers against it. and possible future variants ”.